K
Kate Sixt
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Jun 24, 2026
How We Can Keep Biotech in Check with Dr. Kate Sixt of USDA
3:17
3:26
3:35
A
3:12Anya GrondalskiHOST
Just talk to me about your process about figuring out how you wanted to give your speech.

Kate SixtGUEST
So I think first of all, as you mentioned, it's such a diverse group and they have so much expertise.

Kate SixtGUEST
And so from that perspective, I thought, first of all, what could I talk about that would actually be interesting for them? Right.

Kate SixtGUEST
So if they know so much more about so many different aspects than I do, what could I tell them that's new and that would be appealing to most of the audience.
A
4:35Anya GrondalskiHOST
On a micro and a macro level, so individual organizations, but also countries, when they are working towards greater development in bioengineering and innovation, what are sort of some pillars that you can call out that they need to be thinking about in their governance frameworks or their ethical codes that they're building as they're developing?